Lv1
36 积分 2025-08-22 加入
10.1039/d6bm00808a
11天前
已完结
Abstract 2667: RG7287, a novel humanized anti-CDCP1 antibody with superior preclinical in vivo efficacy in combination with Paclitaxel
4个月前
已完结
Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer
11个月前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
1年前
已完结
皖公网安备34019202002308
